Fig. 2From: The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patientsKaplan–Meier plots of progression-free survival (a) and overall survival (b) of CTC-positive (≥5 CTCs/7.5 mL blood) MBC patients by CTC-HER2 statusBack to article page